ITeos Therapeutics Inc

NASDAQ:ITOS  
27.39
+0.04 (+0.15%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)964.43M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.5 Million
Adjusted EPS-$0.53
See more estimates
10-Day MA$27.32
50-Day MA$27.23
200-Day MA$28.40
See more pivots

ITeos Therapeutics Inc Stock, NASDAQ:ITOS

139 Main Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.339.217.0161
Number of Employees: 62

Description

iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA.